ArticleEuropean journal of nuclear medicine and molecular imaging2022
EANM position on the in-house preparation of radiopharmaceuticals.
Article in European journal of nuclear medicine and molecular imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0.European journal of nuclear medicine and molecular imaging · 2024Guideline
- Liquid chromatographic determination of enantiomeric purity of [EJNMMI radiopharmacy and chemistry · 2026Article
- How Regulation 536/2014 Is Changing Academic Research with Therapeutic Radiopharmaceuticals: A Local Experience.Pharmaceuticals (Basel, Switzerland) · 2025Article
- Strategic Objectives of Nanotechnology-Driven Repurposing in Radiopharmacy-Implications for Radiopharmaceutical Repurposing (Beyond Oncology).Pharmaceutics · 2025Review
- ARTnet Perspectives and Contributions to Theranostics.World journal of nuclear medicine · 2025Review
- To be GMP or not to be- a radionuclide's question.EJNMMI radiopharmacy and chemistry · 2025Article
- Review
- Production of [EJNMMI radiopharmacy and chemistry · 2024Article
- Radiopharmaceutical small-scale preparation in Europe: will we be able to harmonize the situation?EJNMMI radiopharmacy and chemistry · 2024Review
- Production and regulatory issues for theranostics.The Lancet. Oncology · 2024Review
- Automated radiolabelling of [EJNMMI radiopharmacy and chemistry · 2024Article
- Position paper to facilitate patient access to radiopharmaceuticals: considerations for a suitable pharmaceutical regulatory framework.EJNMMI radiopharmacy and chemistry · 2024Article
- The revision of the pharmaceutical legislation - it is time to act for nuclear medicine in Europe.European journal of nuclear medicine and molecular imaging · 2023Article
- Highlight selection of radiochemistry and radiopharmacy developments by editorial board.EJNMMI radiopharmacy and chemistry · 2023Review
- Radiochemistry for positron emission tomography.Nature communications · 2023Review
- Radiometal chelators for infection diagnostics.Frontiers in nuclear medicine · 2023Article
- Cyclotron Production of Gallium-68 Radiopharmaceuticals Using thePharmaceutics · 2022Review
- Efficiency ofEJNMMI physics · 2022Article
- Cyclotrons Operated for Nuclear Medicine and Radiopharmacy in the German Speaking D-A-CH Countries: An Update on Current Status and Trends.Frontiers in nuclear medicine · 2022Article
- Radiopharmaceutical good practices: Regulation between hospital and industry.Frontiers in nuclear medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The EANM herewith clearly expresses its commitment and support to the non-commercial in-house preparation of radiopharmaceuticals for direct use in accordance with European and national regulations.
Indexed as
Identifiers
35050391What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.